A glimpse into the future of
medicines
By DR DAVID MONTGOMERY,
UK and Republic of Ireland Medical
Director for Oncology
I believe we’re at the beginning of one of the
most exciting, but challenging, periods of
change healthcare in this countr...
But what contribution are we making in the
pharmaceutical industry?
Well, our approach to developing medicines is
changing.
Medicines are becoming more targeted than they
have ever been. As an example, the treatment of
non small cell lung cancer ...
New developments and innovations in the future
have the potential to improve health further.
Regenerative medicine is alre...
It is vital, therefore, that we create the right
environment for the latest, most up to date
medicines to be used here in ...
First, we must create the right conditions for the
uptake of innovative medicines. A cultural
change requires strong leade...
Second, we must ensure that the system is
structured in a way that allows the absolute best
use of medicines available, me...
The incredible pace of change and innovation in
healthcare presents us with an enormous prize -
better health and new trea...
Upcoming SlideShare
Loading in...5
×

S196 - Day 1 - 1045 - Authentic, successful and sustainable partnerships to transform care

490

Published on

Health and Care Innovation Expo 2014, Pop-up University

S196 - Day 1 - 1045 - Authentic, successful and sustainable partnerships to transform care

Dr David Montgomery

#Expo14NHS

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
490
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

S196 - Day 1 - 1045 - Authentic, successful and sustainable partnerships to transform care

  1. 1. A glimpse into the future of medicines By DR DAVID MONTGOMERY, UK and Republic of Ireland Medical Director for Oncology
  2. 2. I believe we’re at the beginning of one of the most exciting, but challenging, periods of change healthcare in this country has ever experienced. A combination of cutting edge science and new technology, accompanied by the desire to continually evaluate the way we do things, has the potential to transform patient care.
  3. 3. But what contribution are we making in the pharmaceutical industry? Well, our approach to developing medicines is changing.
  4. 4. Medicines are becoming more targeted than they have ever been. As an example, the treatment of non small cell lung cancer has been transformed by better understanding of how those cancers develop and grow, which allows us to be smarter in developing medicines and improve patient outcomes. These more strategically designed ‘stratified’ medicines will empower doctors to provide the right medicine, to the right patient, at the right time, ensuring NHS budget is invested in the most efficient way.
  5. 5. New developments and innovations in the future have the potential to improve health further. Regenerative medicine is already harnessing the power of stem cells to help the body regenerate itself, focusing on treating the disease not just the symptoms - a potential game changer when considering chronic diseases in our ageing population. In Britain, we lag behind many other European countries in terms of health outcomes. For example, by the Government’s own estimates, if England was to achieve cancer survival rates at the European best, then 10,000 lives could be saved each year.
  6. 6. It is vital, therefore, that we create the right environment for the latest, most up to date medicines to be used here in Britain, to equip doctors with the medicines they need to treat patients and improve health outcomes whilst delivering long-term value for the NHS. This means two things…
  7. 7. First, we must create the right conditions for the uptake of innovative medicines. A cultural change requires strong leadership from Government, to give approval bodies like NICE the mandate to say yes to new medicines, and in doing so drive innovation and investment in the UK.
  8. 8. Second, we must ensure that the system is structured in a way that allows the absolute best use of medicines available, meaning that they are prescribed by health care professionals and used by patients in the optimum way.
  9. 9. The incredible pace of change and innovation in healthcare presents us with an enormous prize - better health and new treatments. Scientists, Government, doctors, industry and patients must work together to ensure we reap the benefits. Real term change will require a trusted, collaborative approach to addressing the challenges of an aging population and the increase in chronic disease that accompanies it, and to create a sustainable healthcare system fit for the future.
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×